Incretin-Based Diabetes Drugs Not Tied to Heart Failure Hospitalizations (FREE)

By Kelly Young Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, FASAM Use of incretin-based drugs for type 2 diabetes — including dipeptidyl-peptidase 4 (DPP-4) inhibitors and glucagon-like peptide 1 analogues — is not associated with increased risk for …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news